Status:
COMPLETED
Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
HTLV-I
Eligibility:
All Genders
18+ years
Brief Summary
Human T-lymphotrophic virus type I (HTLV-I) is endemic in southern Japan and the Caribbean, but disease manifestations differ across geographic regions. Though age, gender, and route of infection may ...
Detailed Description
Southern Japan and the Caribbean are both endemic for human T-lymphotropic virus type I (HTLV-I) infection. In these areas, however, epidemiology of HTLV-I appears to differ. Various observations from...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Healthy blood donors in Kingston, Jamaica.
- All HTLV-I positive donors and age-, sex-matched HTLV-1 negative donors (controls) will be enrolled.
Exclusion
Key Trial Info
Start Date :
January 17 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 11 2011
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00339807
Start Date
January 17 2002
End Date
August 11 2011
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of the West Indies
Kingston, Jamaica